Abstract
Technical improvements in head and neck cancer radiotherapy over the last decade have resulted in substantial reductions in dose to organs-at-risk. For a mix of tumors, we saw less xerostomia moving from 3D-conformal to more advanced techniques. For oropharynx-only there were additional improvements, including in global quality-of-life and sticky saliva.
Original language | English |
---|---|
Pages (from-to) | 298-303 |
Number of pages | 6 |
Journal | Radiotherapy and Oncology |
Volume | 151 |
DOIs | |
Publication status | Published - Oct 2020 |
Funding
Verdonck-de Leeuw received research grants from the Dutch Cancer Society, Alpe d’HuZes Foundation, Netherlands Organization for Health Research and Development (ZonMW), Pink Ribbon, SAG Foundation, Zilveren Kruis health care insurance company, CZ health care insurance company, Danone Ecofund, Nutricia, Dutch Society Head and Neck Cancer Patients, Michel Keijzer Foundation, Red-kite distributor of eHealth tools, and Bristol Meyers Squibb, all outside the submitted work.
Funders | Funder number |
---|---|
Alpe d’HuZes Foundation | |
Danone Ecofund, Nutricia, Dutch Society Head and Neck Cancer Patients | |
Dutch Cancer Society | |
Michel Keijzer Foundation | |
Netherlands Organization for Health Research and Development | |
SAG Foundation | |
Bristol-Myers Squibb | |
ZonMw |
Keywords
- Head and neck radiotherapy
- Organ at risk sparing
- Patient reported outcome
- Quality of life